from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3526/kshA

LFCtreatmentdescriptionclass of inhibitor

0.857

Amikacinug/mL Amikacintranslation

0.287

Cap5-10ug/mL Capreomycintranslation

1.308

Rox10-50 ug/mL Roxithromycintranslation

0.794

SM2-5 ug/mL Streptomycintranslation

0.619

Tet5-10 ug/mL Tetracyclinetranslation

-1.403

Rif0.2-5ug/mL Rifampicintranscription

-0.834

Rifp0.1-0.5ug/mL Rifapentinetranscription

2.112

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.690

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.494

CPZ10-50 ug/mL Chlorpromazinerespiration

0.901

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.123

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.370

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.931

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.426

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.167

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.151

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.533

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.415

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.044

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.641

KCN5-20 ug/mL Potassium cyaniderespiration

-0.118

NaN30.2-2 mM Sodium aziderespiration

-0.053

Nigericin50 uM Nigericinrespiration

-0.099

TRC10-150 ug/mL Triclosanrespiration

2.170

TRZ10-25 ug/mL Thioridazinerespiration

1.557

Valinomycin0.5-10 uM Valinomycinrespiration

-0.093

ZnSO42 mM ZnSO4respiration

0.683

menadione6-10 ug/mL Menadionerespiration

4.048

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.366

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.156

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.219

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.465

NRP_1Non-replicating persistence stage 1dosRassociated

-0.234

Amp0.2mg/mL AmpicillincellWall

-0.484

Cephalexin20-100 ug/mL CephalexincellWall

-0.499

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.582

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.395

EMB10-20 ug/mL EthambutolcellWall

-0.268

Eta12-40 ug/mL EthionamidecellWall

-0.368

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.417

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.156

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.177

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.425

BZA0.12 mg/mL BenzamidearomaticAmides

-0.405

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.397

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.782

H2O24 mM hydrogen peroxideDNAdamaging

-0.631

Levo10 ug/mL LevofloxacinDNAdamaging

-0.805

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.219

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.474

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.998

UVUV-irradiationDNAdamaging

0.617

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.278

Antimycin12.5-50 ug/mL Antimycin A?

-0.376

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.566

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.225

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.773

PA8240.2-2 ug/mL PA-824?

0.050

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.793

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.128

Verapamil50 uM Verapamil?

-0.361

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.281

methoxatin10-20 ug/mL Methoxatin?